ArticleBMC endocrine disorders2026
Threshold effect of the METS-VF index on hyperuricemia in adults with hypertension: a cross-sectional study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundHyperuricemia (HUA) is a major public health concern that is closely linked to obesity. The novel visceral adiposity index (METS-VF) demonstrates significant associations with multiple chronic diseases, yet its association with HUA risk in hypertensive patients remains unclear. This study aimed to investigate this association in a Chinese hypertensive population.
methodsThis study utilized data from the Chinese Hypertension Registry Study, including 13,341 hypertensive patients. Data collection was conducted through standardized questionnaires, physical examinations, and laboratory tests. We evaluated the association between METS-VF and HUA using multivariate logistic regression models. Robustness was assessed via multivariable-adjusted models and subgroup analyses.
resultsThe overall prevalence of HUA was 55.3%. Each unit increase in METS-VF was associated with a 8.48 (95% CI: 6.64, 10.32) µmol/L increase in serum uric acid levels and a 25% higher risk of HUA (OR = 1.25; 95% CI: 1.20, 1.30). HUA risk increased significantly across increasing METS-VF quartiles (P for trend < 0.001). Further analysis revealed a non-linear, threshold relationship. Subgroup analysis indicated a stronger association in women (P for interaction < 0.001).
conclusionIn patients with hypertension, the visceral adiposity index (METS-VF) was positively associated with the risk of hyperuricemia (HUA).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.